Filing Details

Accession Number:
0001628280-23-006533
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-06 16:29:53
Reporting Period:
2023-03-02
Accepted Time:
2023-03-06 16:29:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600620 Aurinia Pharmaceuticals Inc. AUPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1179552 Jr M George Milne #1203-4464 Markham Street
Victoria A1 V8Z7X8
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-02 20,000 $8.91 70,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.86 to $8.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.